Increased physiological dead space during exercise after bronchodilation in cystic fibrosis.
Bicycle ergospirometry was performed on 14 patients with cystic fibrosis (CF), for evaluating the effects of salbutamol and theophylline on the ventilatory response to exercise. After 1 week without bronchodilator therapy the patients cycled at 1/3 and 2/3 of their individual maximal working capacity (Wmax). The test was repeated three times after treatment with salbutamol, theophylline, or both drugs, respectively. After the combined therapy, physiological deadspace, ventilation, ventilatory equivalent of oxygen, and end-expiratory oxygen pressure increased significantly during steady state exercise at 1/3 Wmax. Similar, although not statistically significant changes, were observed after monotherapy with salbutamol or theophylline and during exercise at 2/3 Wmax. These effects could not be predicted by any lung function tests at rest or by the Shwachman-Kulczycki score. The results indicate that in some patients with CF bronchodilators can impair lung function during exercise. In conclusion, the effects of medication on exercise performance of patients with CF have to be considered. Especially, the use of bronchodilators requires a careful evaluation of their real benefit in each individual patient.
Kusenbach
G
G
Department of Pediatrics, Technical University of Aachen, Federal Republic of Germany.
Friedrichs
F
F
Skopnik
H
H
Heimann
G
G
D000293:Adolescent; D000403:Airway Resistance; D000420:Albuterol / Q000627:therapeutic use*; D001980:Bronchi / Q000503:physiopathology; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D005082:Physical Exertion; D012123:Pulmonary Ventilation; D012126:Respiratory Dead Space; D013806:Theophylline / Q000627:therapeutic use*; D014797:Vital Capacity
D013806:Theophylline; D000420:Albuterol